Inhibition of osteopontin reduce the cardiac myofibrosis in dilated cardiomyopathy via focal adhesion kinase mediated signaling pathway

American Journal of Translational Research

Volumn 8, Issue 9, 2016, Pages 3645-3655

  Zhao, Hui ^a   Wang, Wei ^a   Zhang, Jie ^a   Liang, Tuo ^a   Fan, Guang Pu ^a   Wang, Zhi Wei ^a   Zhang, Pei De ^a   Wang, Xu ^a   Zhang, Jing ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Cardiac fibrosis; Dilated cardiomyopathy (DCM); Fibroblast; Focal Adhesion Kinase (FAK); Osteopontin (OPN)

Indexed keywords

COLLAGEN TYPE 1; FOCAL ADHESION KINASE; MESSENGER RNA; OSTEOPONTIN; SMAD PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

EID: 84988909629     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G and Anversa P. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994; 89: 151-163.
2. Bortone AS, Hess OM, Chiddo A, Gaglione A, Locuratolo N, Caruso G and Rizzon P. Functional and structural abnormalities in patients with dilated cardiomyopathy. J Am Coll Cardiol 1989; 14: 613-623.
3. Moore-Morris T, Guimaraes-Camboa N, Yutzey KE, Puceat M and Evans SM. Cardiac fibroblasts: from development to heart failure. J Mol Med (Berl) 2015; 93: 823-830.
4. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M and Marwick TH. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 2004; 110: 558-565.
5. Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL and Hsueh WA. Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest 1996; 98: 2218-2227.
6. Murry CE, Giachelli CM, Schwartz SM and Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994; 145: 1450-1462.
7. Collins AR, Schnee J, Wang W, Kim S, Fishbein MC, Bruemmer D, Law RE, Nicholas S, Ross RS and Hsueh WA. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. J Am Coll Cardiol 2004; 43: 1698-1705.
8. Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, Fleck E and Hsueh WA. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 1997; 96: 3063-3071.
9. Singh M, Foster CR, Dalal S and Singh K. Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI. J Mol Cell Cardiol 2010; 48: 538-543.
10. Renault MA, Robbesyn F, Reant P, Douin V, Daret D, Allieres C, Belloc I, Couffinhal T, Arnal JF, Klingel K, Desgranges C, Dos Santos P, Charpentier F and Gadeau AP. Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy. Circ Heart Fail 2010; 3: 431-439.
11. O’Regan A and Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 2000; 81: 373-390.
12. Oldberg A, Franzen A and Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A 1986; 83: 8819-8823.
13. Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, Ge X, Fiel MI and Nieto N. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V) beta(3) engagement and PI3K/pAkt/NFkap-paB signaling. Hepatology 2012; 55: 594-608.
14. Franchini KG. Focal adhesion kinase-the basis of local hypertrophic signaling domains. J Mol Cell Cardiol 2012; 52: 485-492.
15. Han M, Wen JK, Zheng B, Liu Z and Chen Y. Blockade of integrin beta3-FAK signaling pathway activated by osteopontin inhibits neointimal formation after balloon injury. Cardiovasc Pathol 2007; 16: 283-290.
16. Zhang P, Wang W, Wang X, Wang X, Song Y, Zhang J and Zhao H. Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease. Int J Cardiol 2013; 168: 3200-3207.
17. Fan GP, Wang W, Zhao H, Cai L, Zhang PD, Yang ZH, Zhang J and Wang X. Pharmacological Inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis in Mice Cardiac Fibroblast and Post-Myocardial-Infarction Models. Cell Physiol Biochem 2015; 37: 515-526.
18. Juan F, Wei D, Xiongzhi Q, Ran D, Chunmei M, Lan H, Chuan Q and Lianfeng Z. The changes of the cardiac structure and function in cTn-TR141W transgenic mice. Int J Cardiol 2008; 128: 83-90.
19. Lagares D and Kapoor M. Targeting focal adhesion kinase in fibrotic diseases. BioDrugs 2013; 27: 15-23.
20. Stawowy P, Blaschke F, Pfautsch P, Goetze S, Lippek F, Wollert-Wulf B, Fleck E and Graf K. Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur J Heart Fail 2002; 4: 139-146.
21. Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I and Hiramori K. Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy. Eur J Heart Fail 2005; 7: 755-762.
22. Lopez B, Gonzalez A, Lindner D, Westermann D, Ravassa S, Beaumont J, Gallego I, Zudaire A, Brugnolaro C, Querejeta R, Larman M, Tschope C and Diez J. Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase? Cardiovasc Res 2013; 99: 111-120.
23. Behnes M, Brueckmann M, Lang S, Espeter F, Weiss C, Neumaier M, Ahmad-Nejad P, Borg-grefe M and Hoffmann U. Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure. Eur J Heart Fail 2013; 15: 1390-1400.
24. Rosenberg M, Zugck C, Nelles M, Juenger C, Frank D, Remppis A, Giannitsis E, Katus HA and Frey N. Osteopontin, a new prognostic biomarker in patients with chronic heart failure. Circ Heart Fail 2008; 1: 43-49.
25. MacLean J and Pasumarthi KB. Signaling mechanisms regulating fibroblast activation, phenoconversion and fibrosis in the heart. Indian J Biochem Biophys 2014; 51: 476-482.
26. Moraes JA, Frony AC, Dias AM, Renovato-Martins M, Rodrigues G, Marcinkiewicz C, Assreuy J and Barja-Fidalgo C. Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells. Atherosclerosis 2015; 243: 477-485.
27. Zhao XK, Cheng Y, Liang Cheng M, Yu L, Mu M, Li H, Liu Y, Zhang B, Yao Y, Guo H, Wang R and Zhang Q. Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis. Sci Rep 2016; 6: 19276.
28. Kasner M, Westermann D, Lopez B, Gaub R, Escher F, Kuhl U, Schultheiss HP and Tschope C. Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol 2011; 57: 977-985.
29. Lopez B, Ravassa S, Gonzalez A, Zubillaga E, Bonavila C, Berges M, Echegaray K, Beaumont J, Moreno MU, San Jose G, Larman M, Querejeta R and Diez J. Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure. J Am Coll Cardiol 2016; 67: 251-260.
30. Burlew BS and Weber KT. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin 2000; 18: 435-442.
31. Dai J, Peng L, Fan K, Wang H, Wei R, Ji G, Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W and Guo Y. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 2009; 28: 3412-3422.
32. Wolak T, Kim H, Ren Y, Kim J, Vaziri ND and Nicholas SB. Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int 2009; 76: 32-43.